IGC Pharma (IGC) Debt Ratio (2011 - 2026)

IGC Pharma (IGC) has 16 years of Debt Ratio data on file, last reported at 0.02 in Q1 2026.

• Debt Ratio for Q1 2026 came in at 0.02, up 54.93% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.02 (up 54.93% YoY), and the FY2026 annual result was 0.02, up 54.93% from the prior year.
• Debt Ratio declined to 0.02 in Q1 2026 per IGC's latest filing, from 0.05 in the prior quarter.
• Over five years, Debt Ratio peaked at 0.05 in Q4 2025 and troughed at 0.01 in Q1 2022.
• A 5-year average of 0.01 and a median of 0.01 in 2024 frame the typical range for Debt Ratio.
• The sharpest annual moves came in 2022 and 2025: Debt Ratio slumped 66.12% in 2022, then surged 242.5% in 2025.
• A 5-year view of Debt Ratio shows it stood at 0.01 in 2022, then jumped by 74.46% to 0.01 in 2023, then gained by 20.43% to 0.01 in 2024, then surged by 242.5% to 0.05 in 2025, then plunged by 53.05% to 0.02 in 2026.
• Business Quant data shows IGC's Debt Ratio at 0.02 in Q1 2026, 0.05 in Q4 2025, and 0.01 in Q3 2025.